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Identification of an mtDNA Mutation Hot Spot
in UV-Induced Mouse Skin Tumors Producing Altered
Cellular Biochemistry
Jana Jandova1,3, Alex Eshaghian2,3, Mingjian Shi2,3, Meiling Li2, Lloyd E. King2, Jaroslav Janda1
and James E. Sligh1
There is increasing awareness of the role of mtDNA alterations in the development of cancer, as mtDNA point
mutations are found at high frequency in a variety of human tumors. To determine the biological effects of
mtDNA mutations in UV-induced skin tumors, hairless mice were irradiated to produce tumors, and the tumor
mtDNAs were screened for single-nucleotide changes using temperature gradient capillary electrophoresis
(TGCE), followed by direct sequencing. A mutation hot spot (9821insA) in the mitochondrially encoded tRNA
arginine (mt-Tr) locus (tRNAArg) was discovered in approximately one-third of premalignant and malignant skin
tumors. To determine the functional relevance of this particular mutation in vitro, cybrid cell lines containing
different mt-Tr (tRNAArg) alleles were generated. The resulting cybrid cell lines contained the same nuclear
genotype and differed only in their mtDNAs. The biochemical analysis of the cybrids revealed that the mutant
haplotype is associated with diminished levels of complex I protein (CI), resulting in lower levels of baseline
oxygen consumption and lower cellular adenosine triphosphate (ATP) production. We hypothesize that this
specific mtDNA mutation alters cellular biochemistry, supporting the development of keratinocyte neoplasia.
Journal of Investigative Dermatology (2012) 132, 421–428; doi:10.1038/jid.2011.320; published online 20 October 2011
INTRODUCTION
Theories of mitochondrial involvement on cancer date back to
Warburg’s theories that impairment of oxidative phosphoryla-
tion (OXPHOS) and increased use of glycolysis in tumors were
thought to be critical steps in the development of cancer
(Warburg, 1956). There is growing evidence that some nuclear-
encoded OXPHOS genes have dual functions in energy
generation and tumor suppression (Eng et al., 2003). Mutations
in the fumarate hydratase gene have been linked to uterine
leiomyomas and renal cell carcinomas, and mutations in
subunits of the succinate dehydrogenase gene (SDHB, SHDC,
and SDHD) have been associated with paragangliomas,
pheochromocytomas, and renal cell carcinomas (Baysal et al.,
2000; Niemann and Muller, 2000; Astuti et al., 2001; Lehtonen
et al., 2004; Vanharanta et al., 2004). The role of mtDNA point
mutations in the development of cancer has been suggested
(Polyak et al., 1998; Petros et al., 2005), as they have been found
in high frequency in tumors. These mtDNA mutations were
often homoplasmic (the exclusive mtDNA species), implying a
genetic selection for these mtDNA changes in the development
of cancers. mtDNA mutations have been identified in epithelial
tumors, tumors of the musculoskeletal, central nervous, and
endocrine systems (Brandon et al., 2006; Chatterjee et al., 2006;
Lu et al., 2009; Verma and Kumar, 2007).
mtDNA mutations have been studied in human skin
cancer (Birch-Machin et al., 1998; Berneburg et al., 2006;
Birch-Machin, 2006; Eshaghian et al., 2006). One of the
limitations in the analysis of mtDNA changes in humans is
that they have many mtDNA polymorphisms that represent
diverse cultural origins. The hairless mouse model system is
useful for analysis of mtDNA changes in nonmelanoma skin
cancer, as this model is a well-established way to generate
epidermal tumors that are similar to those seen in human
squamous cell carcinoma and the mtDNA is similar in size
and structure to that of humans. Studying mtDNA changes in
the laboratory mouse offers a distinct advantage of mtDNA
homogeneity, which arises from a recent common female
ancestor, and allows for a facilitated analysis of what mtDNA
changes may be pathogenic (Ferris et al., 1983). To determine
whether mtDNA changes have a role in nonmelanoma skin
cancer formation, tumors were induced in hairless mice by
& 2012 The Society for Investigative Dermatology www.jidonline.org 421
ORIGINAL ARTICLE
Received 17 July 2011; accepted 11 August 2011; published online 20
October 2011
1Department of Medicine, Dermatology Division, Arizona Cancer Center,
University of Arizona and the Southern Arizona VA Healthcare System,
Tucson, Arizona, USA and 2VA Tennessee Valley Healthcare System,
Dermatology Division of the Department of Medicine, and Department of
Cell and Developmental Biology, Vanderbilt University Medical Center,
Nashville, Tennessee, USA
Correspondence: James E. Sligh, Division of Dermatology, University of
Arizona, 1515 North Campbell Avenue, Tucson, Arizona 85724, USA.
E-mail: jsligh@azcc.arizona.edu
3These authors contributed equally to this work.
Abbreviations: ATP, adenosine triphosphate; CI, II, III, IV, V, mitochondrial
complexes I, II, III, IV, V; mt-Tr, mitochondrially encoded tRNA arginine;
OXPHOS, oxidative phosphorylation; ROS, reactive oxygen species; TGCE,
temperature gradient capillary electrophoresis; tRNA, transfer RNA
UV radiation. The DNA of these tumors was analyzed for
mtDNA changes. A specific mutation in the mitochondrially
encoded tRNA arginine (mt-Tr) locus occurred at high
frequency, and this mutation was studied in a cybrid system
to identify the specific biochemical changes imparted by the
mtDNA mutation that are supportive of a tumorigenic
phenotype.
RESULTS
To determine whether mtDNA changes occur in murine
nonmelanoma skin cancers, tumors were induced in hairless
SKH1 mice by UV irradiation (Figure 1a and b). The entire
mouse mtDNA was screened for mutations using genomic
DNA isolation from tumors, multiplexed PCR of the entire
mtDNA, restriction endonuclease digestion (Figure 2a), and
heteroduplex analysis by multiplexed temperature gradient
capillary electrophoresis (TGCE; Figure 2b and c). A mutation
hot spot was identified in the gene encoding the mitochon-
drial tRNA for arginine (mt-Tr). The presence of an additional
peak for fragment 2 (arrow in Figure 2b) is indicative of
a heteroduplex formation and the detection of a somatic
mutation. Minimally irradiated skin from the ventral surface
of each mouse was used as a control and was found
to contain only homoduplexes, indicating the lack of any
mutation. A 9821insA mutation in the mt-Tr locus was
defined by DNA sequencing (Figure 2d–f). This mutation
predicts an insertion of an extra A in a homopolymeric tract
in the dihydrouridine loop of the mitochondrial tRNAArg.
The B6 mt-Tr gene contains a homopolymeric tract of
eight consecutive adenosine residues (Figure 2d). Tumors
often contained an additional adenosine residue in this
tract (Figure 2e). This change was confirmed by re-amplify-
ing and sequencing the gene in the reverse orientation,
as well as by sequencing with Pfu DNA polymerase.
This mutation was commonly seen in both heteroplasmy
(Figure 2f) and homoplasmy (Figure 2e). The mt-Tr 9821insA
mutation was found in approximately one-third of prema-
lignant and malignant samples; however, it was absent in
normal skin and other nontumor internal organs. The alleles
present in the tumors include both heteroplasmic and
homoplasmic 9821insA containing nine consecutive A bases
instead of the eight that are normally found in this strain.
Figure 1c shows the frequency of mutant mt-Tr 9821insA
alleles in SKH1 mice that were irradiated with UV to induce
cutaneous tumors. The ‘‘no tumor’’ skin is normal skin
taken from the belly at the time of excision. ‘‘Other tissues’’
are healthy brain, liver, spleen, heart, kidney, and lung
tissues taken from the same mice at the time of harvesting the
skin tissues.
Structural analysis modeled with mfold software (Zuker,
2003) predicts the murine mt-Tr 9821insA allele containing
nine adenosine residues to have potential altered secondary
structures (Figure 3b and c). One of these structures is
predicted to be similar to the mt-Tr wild-type allele contain-
ing eight consecutive adenosine residues (Figure 3a), whereas
the other structure (Figure 3c) is markedly different and
energetically more stable (DG¼11.3 kcal mol–1) than the
former structure (DG¼9.8 kcal mol–1). As the transfer RNA
(tRNA) structure is critical to its function, it is proposed that
this altered structure would be more abundant and unlikely to
be functional. At temperatures slightly lower than 37 1C, as
are encountered in the skin, nonfunctional isoforms may be
even more energetically favored over the typical wild-type
allele structure. Thus, it is expected that cells containing
mt-Tr 9821insA mutation allele would have affected protein
synthesis of all 13 mtDNA-encoded peptides.
We used a naturally occurring allelic variant contained
within the Balb/c mouse strain as the source of 9821insA
allele. To determine the functional relevance of this single-
nucleotide mutation, cybrid cells were generated. We
produced two cybrid cell lines that had identical nuclear
background to murine L cells but differed only in their
mtDNA. In this way, the two alleles could be compared on a
neutral nuclear genetic background. We analyzed the effects
of this nucleotide insertion in the mtDNA by studying cybrids
that harbor alterations at this locus.
We characterized the biochemistry of the cybrid cells by
first examining cellular adenosine triphosphate (ATP) levels.
Figure 4a shows that the cellular ATP levels were significantly
lower in mtBALB cybrids compared with mtB6 cybrids in
media containing glucose or galactose. Next, we examined
respiratory activity of the cybrid lines by measuring cellular
oxygen consumption. We observed that mtBALB cybrids
consumed less oxygen compared with mtB6 cybrid cells
overall under the basal conditions. After rotenone was added
to inhibit CI, digitonin was used to permeabilize the cells,
and the activity of CII was measured after adding the
substrates adenosine diphosphate and succinate. Although
the baseline levels of respiration were reduced in the mtBALB
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Figure 1. Induced cutaneous tumors and frequency of point mutation in
the mt-Tr locus (tRNAArg). (a) Dorsal surface of a hairless mouse with
UV-induced cutaneous tumors. (b) Hematoxylin and eosin histology stain of
one of these tumors is consistent with a diagnosis of squamous papilloma.
The height of the papilloma equals 2 mm. (c) The percentage of samples with
various diagnoses harboring a mutant mt-Tr 9821insA allele is shown.
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cybrids compared with mtB6, they displayed significantly
enhanced oxygen consumption in the presence of CII
substrates (Figure 4b). To better understand the observed
changes in respiration, we sought to characterize the levels of
OXPHOS proteins contained within the mitochondria. Using
western blotting, we compared the protein levels of all
mitochondrial OXPHOS complexes of mtB6 and mtBALB
cybrid cells (Figure 5a). The levels of CI were significantly
reduced in mtBALB cybrids compared with mtB6, as
measured by densitometry. The levels of complexes II, III,
IV, and V showed no significant differences between the cell
lines (Figure 5b). Thus, mtBALB cybrids have a diminished
overall respiratory activity compared with mtB6 cybrids, but
they are more responsive to CII substrates.
DISCUSSION
The tumors generated in the mouse occurred primarily on the
UV-exposed dorsal surfaces of the animals and were malig-
nant squamous cell carcinomas or premalignant squamous
papillomas by microscopic analysis performed by a derma-
topathologist. One particular point mutation in the mt-Tr
locus (tRNAArg) was very common, occurring in approxi-
mately one-third of squamous papilloma samples and
squamous cell carcinoma samples (Figure 1c); however, it
was not detected in normal skin from the minimally irradiated
ventral surface of animals or in normal-appearing skin from
the irradiated dorsal surface of the animals, nor was it
detected in internal organs, indicating that these induced
changes occurred in the process of tumor development. The
mouse mitochondrial mt-Tr (tRNAArg) gene appears to be a
hot spot for UV-induced mutations having the sequence
containing a homopolymeric tract of eight consecutive
adenosine residues. The occurrence of an insertion mutation
within a homopolymeric tract may highlight a potential
weakness in the ability of mitochondrial DNA polymerase-g
to repair UVA-induced damage within the mtDNA (Longley
et al., 2001). Such mutations may be important in tumor
progression, as mtDNA changes lead to increased oxidative
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Figure 2. Restriction analysis, temperature gradient capillary electrophoresis (TGCE) multiplex analysis, and DNA sequencing detect mtDNA mutation hot
spot. (a) Resolution of undigested PCR products covering the entire mtDNA (left) and digested restriction fragments (right) are shown in an inverted image
of a 1.5% agarose gel stained with ethidium bromide. (b) TGCE output from a single capillary. Unknown (from a tumor, top), control (bottom), and mixed
(center) mouse DNA samples were analyzed. Fragments 1, 3, and 4 have only a single peak, which is indicative of complete homoduplex formation and the
lack of a mutation. The presence of an additional peak for fragment 2 in the unknown and mixed samples is indicative of heteroduplex formation and the
detection of a somatic mutation. (c) The gel image of all four fragments. DNA sequencing of the mt-Tr locus in control and tumor DNA samples in reverse
orientation. (d) Partial DNA sequence of wild-type allele and (e) homoplasmic or (f) heteroplasmic 9821insA mutant allele.
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stress, which can be mitogenic to cells (unpublished observa-
tions). We generated cybrid cell lines to identify biochemical
and molecular changes because of this genetic alteration in
the mt-Tr gene. As tRNAs are required for protein synthesis,
the levels of all mtDNA-encoded polypeptides can be
altered. The western blot analysis revealed that the mutant
haplotype is associated with diminished levels of complex I
protein, which is likely caused because a portion of the
9821insA tRNAs are nonfunctional. These decreased levels
of complex I protein resulted in lower levels of baseline
oxygen consumption and lower cellular ATP production. The
mtBALB cybrids are more responsive to CII substrates. CII
subunits are entirely encoded within the nuclear DNA and
these proteins are synthesized on cytoplasmic ribosomes
before import into the mitochondria. Enhanced CII substrate
sensitivity may reflect a compensatory change by the nucleus
to compensate for lower overall cellular ATP levels.
The biochemical differences between the cybrids suggest
that energetic metabolism may be directly linked to neoplastic
behavior. This notion of glycolytic metabolism as a key
component of cellular transformation was proposed more than
50 years ago (Warburg, 1956). A recent study by Ye et al.
(2011) reported that some mitochondrial and energy metabo-
lism-related properties, such as lower oxygen/glucose con-
sumption, and lower intracellular concentrations of ATP
can be used as indicators of lung cancer stem cells. Much
lower rates of ATP synthesis, lower cellular oxygen consump-
tion, and decreased activities of the respiratory chain
complexes were found in breast cancer cells (Ma et al.,
2010). Moreover, downregulation of the catalytic subunit of
the mitochondrial ATP synthase has been found to be a
hallmark of many types of cancer such as liver, kidney, colon,
breast, lung, and squamous esophageal carcinomas and gastric
adenocarcinomas (Formentini et al., 2010). Oncocytic tumors
of the thyroid, kidney, and parathyroids have been shown to
accumulate mtDNA disruptive mutations, the large majority of
which map in respiratory CI genes (Costa-Guda et al., 2007;
Gasparre et al., 2007, 2008, 2009; Mayr et al., 2008;
Zimmermann et al., 2009; Porcelli et al., 2010). In oncocy-
tomas, a consistent loss of CI was found, along with compensa-
tory upregulation of the other respiratory chain complexes
(Zimmermann et al., 2011). The involvement of CI mutations
in cancer has been demonstrated in a recent study of sporadic
breast cancer (Czarnecka et al., 2010).
The oxidative damage generated by UV radiation may
also increase the levels of reactive oxygen species (ROS) to the
point where the cells begin to hyperproliferate and other
carcinogenic phenotypes such as migration and invasiveness
can be triggered. The measurement of proliferative and
migratory changes may be valuable in explaining the higher
incidence of this genetic change in tumors. In addition, the
possible differences in ROS production between the two
cybrid lines should be determined, as ROS levels can support a
role of ROS as specific second messengers (Burdon, 1995; Irani
et al., 1997; Sauer et al., 2001; Liu et al., 2002; Nishikawa,
2008; Mesquita et al., 2010) in signaling cascades involved
in cell proliferation, differentiation, and migration.
Inheritance of these mtDNA changes at the mt-Tr locus in
mice is associated with deafness (Johnson et al., 2001), as well
as with modulation of complex phenotypes such as cognitive
functions (Roubertoux et al., 2003). Different phenotypes
associated with mtDNA variation at the same locus are
common in human mtDNA-associated diseases in which tRNA
mutations, in particular, often produce very pleomorphic
phenotypes such as those seen in human tRNALeu gene
(Wittenhagen and Kelley, 2003). The 9821insA allele may be
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Figure 3. Predicted transfer RNA (tRNA) structures based on sequence. The predicted structures for the tRNA variants generated by mfold software.
(a) Wild-type tRNA isoform with DG¼9.8 kcal mol–1, (b) 9821insA tRNA isoform with DG¼9.8 kcal mol–1, and (c) 9821insA tRNA isoform with
DG¼11.3 kcal mol–1.
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expected to form different structurally distinct isoforms that
may have a normal or possibly nonexistent function. The
balance of functional to nonfunctional isoforms may be quite
tissue specific, depending on local factors such as temperature
or ionic concentrations. Homeostasis imbalance in the organ-
ism may predispose to organ-specific tumor development.
In this study we identify a hot spot for mutations and
demonstrate that this mt-Tr 9821insA allele can alter the
biochemical characteristics of murine cybrid cells. These
profound differences in cellular physiology displayed by the
murine cybrids may contribute to the overall tumorigenic
phenotype of the tumors that harbor this mtDNA change and
may also explain some of the varying predispositions to
developing tissue-specific malignancies in mouse strains
(Krupke et al., 2008). Furthermore, these studies on mouse
mtDNA haplotypes contribute to a better understanding of
human phenotypes associated with mtDNA variation.
MATERIALS AND METHODS
Mice
To study hairless mice with the mitochondrial background of
C57BL/6J (B6), SKH1 hairless male mice (Charles River Laboratories,
Wilmington, MA) were crossed with female B6 mice (The Jackson
Laboratory, Bar Harbor, ME) and the resulting female progenies were
backcrossed 10 times with SKH1. Female F2 mice that were hairless
and albino were selected from each cross for continued back-
crossing with SKH1 male mice. BALB/cJ mice (The Jackson
Laboratory) have mtDNA identical to B6 mice. The only differences
between their mtDNAs are a T to C polymorphism at 9461 and a
9348 G to A change resulting in the amino acid change V248I,
which is thought to be a neutral polymorphism (Moreno-Loshuertos
et al., 2006) and an additional A insertion in the mt-Tr locus resulting
in the expansion of a homopolymeric tract of eight consecutive A
residues to nine consecutive A’s in the pseudouridine loop of the
tRNAArg molecule.
The animal experiments were approved by the institutional
animal care and use committees at the Vanderbilt University and the
University of Arizona.
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Figure 4. The mtBALB cybrid cells have lower adenosine triphosphate (ATP)
production and altered respiratory function compared with mtB6 cybrids.
(a) Cybrid cells were incubated in DMEM supplemented with either glucose
or galactose. The levels of cellular ATP are shown. (b) Fiber optic
investigation of mitochondrial respiratory chain function showing oxygen
consumption was performed without the addition of an exogenous substrate,
and with the addition of specific oxidative phosphorylation (OXPHOS)
substrates or inhibitors. Values represent the mean±SEM of three
independent experiments of five clones. CCCP, carbonyl cyanide
m-chlorophenylhydrazone. Asterisks indicate statistical difference between
mtB6 and mtBALB cybrid cells (*Po0.05, **Po0.005).
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Tumor induction
Cutaneous tumors were induced in hairless SKH1 mice by exposure
to 720 mJ UVA and 60 mJ UVB 5 days per week for 10 weeks. Tumor
formation began several weeks later. Tumors were removed from the
dorsal surface of the animals, along with minimally irradiated skin
from the ventral surface of the animals, and in some cases tumor-free
irradiated skin was removed from the dorsal surface of the animals,
as a control. After killing, non-UV-irradiated tissues including brain,
heart, skeletal muscle, gut, liver, spleen, gonads, and lungs were
isolated. The mtDNA of these UV-protected organs was also used as
controls. Genomic DNA was isolated from each tumor, and mtDNA
was analyzed for single-nucleotide changes using TGCE.
Temperature Gradient Capillary Electrophoresis
DNA extraction was performed using DNeasy kits (Qiagen,
Valencia, CA) or by alkaline lysis and protein precipitation after
proteinase K tissue digestion.
The entire mouse mtDNA was PCR amplified in overlapping
fragments in 8 tubes using 16 mtDNA-specific primer pairs (Table 1).
Each tube contained two primer pairs, and two PCR products were
produced per tube. Thirty cycles of multiplexed PCR were performed
in Ampli-Taq Gold buffer (Applied Biosystems, Carlsbad, CA) with
15 mM MgCl2, according to the manufacturer’s instructions, supple-
mented with additional 25 mM MgCl2, 2 mM dNTP (New England
BioLabs, Ipswich, MA), 5mM primers, 10 mg ml–1 BSA (Promega),
and 9:1 Ampli-Taq Gold/Pfu DNA polymerase (Promega). The
PCR parameters were as follows: an initial denaturation at 95 1C
for 10 minutes, followed by 30 cycles of denaturation at 95 1C for
1 minute, annealing at 57 1C for 1 minute, and elongation at 72 1C
for 3 minutes, with a final elongation at 72 1C for 10 minutes.
Restriction endonuclease digestions of crude PCR products were
performed in the augmented Ampli-Taq Gold buffer without further
supplementation at 37 1C, except for TaqI, which was digested at
65 1C. A volume of 2ml of the appropriate restriction enzyme
(Table 1) was added to every PCR product. Samples were incubated
at 37 1C for 2 hours and then at 65 1C for 60 minutes. To determine
the resolution of all restriction fragments, 5ml of restriction fragments
from each tube was run on 1.5% agarose gel electrophoresis at
10 V cm–1 for 90 minutes.
Heteroduplex species are formed by mixing digested unknown
DNA fragments with control DNA fragments in a 1:1 ratio in a
thermal cycler. The mixed samples are denatured at 951C and
annealed using this profile: a 3-minute denaturation step at 95 1C,
followed by a stepwise reduction in temperature as follows: decrease
from 95 to 80 1C at 3 1C per minute, decrease from 80 to 55 1C at
1 1C per minute, hold for 20 minutes at 55 1C, decrease from 55 to
45 1C at 1 1C per minute, and decrease from 45 to 25 1C at 2 1C per
minute before storage at 4 1C.
TGCE analysis was performed on a Reveal Discovery System
(SpectruMedix, State College, PA). This system performs temper-
ature gradient electrophoresis for DNA variant detection in an
automated capillary array instrument. DNA samples consisting of
homoduplexes and heteroduplexes are separated by capillary
electrophoresis, during which a thermal ramp from 50 to 60 1C for
25 minutes is applied. The injection parameters are 6 kV for
90 seconds and the capillary length is 70 cm. The gel in the capillary
is 2% w/v 7-million mol wt polyethylene oxide dissolved in 1 TBE
buffer with ethidium bromide added at a final concentration of
0.5 mg ml–1. SpectruMedix Check Mate Software was used for
instrument control and data acquisition (acquisition time 65 minutes)
Data were analyzed using SpectruMedix Reveal Software to generate
mutation scoring results for all samples in a plate.
DNA sequencing
Forward (50-TTCTAGTCACAATTCTATCTCTAGGC-30) and reverse
(50-GCATTGTAGTAGGTTGAGATTTTGG-30) primers were designed
for PCR to amplify the mt-Tr gene from total genomic DNA. PCR
samples were prepared in a total volume of 50ml. Each tube contained
1 Taq master Mix (New England BioLabs) containing 10 mM Tris-
HCl, 50 mM KCl, 1.5 mM MgCl2, 25 units ml
–1 Taq DNA polymerase,
0.2 mM dNTPs each, 5% glycerol, 0.08% NP-40, and 0.05% Tween-
20, as well as 250 ng of DNA template and 5mM of both primers. The
PCR parameters were as follows: an initial denaturation at 95 1C for
5 minutes, followed by 30 cycles of denaturation at 95 1C for
30 seconds, annealing at 60 1C for 60 seconds, and elongation at
68 1C for 1 minute, with a final elongation at 68 1C for 5 minutes. PCR
products were then purified using the QIAquick PCR purification kit
(Qiagen) and sequenced on an Applied Biosystems 3730XL DNA
analyzer (Life Technologies, Carlsbad, CA).
Cybrid cell line generation
LMEB3(mtBALB) and LMEB3(mtB6) cells were generated by harvest-
ing mitochondria from brain synaptosomes of B6 and BALB mice
and electrofusing them to a mouse fibroblast LMEB3r0 cell line
that lacked its own mtDNA (Trounce and Wallace, 1996; Trounce
et al., 2000). All cell lines were grown in high glucose (4.5 g l–1) or in
galactose (4.5 g l–1) DMEM (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (Invitrogen, Carlsbad, CA) as indicated.
ATP assay
The amount of cellular ATP was determined using an ATPlite 1step
kit (PerkinElmer, Waltham, MA) based on firefly luciferin/luciferase
(Cree and Andreotti, 1997). Cells were seeded in 96-well plates
(5 104 per well) and allowed to attach for 4 hours. They were then
washed with Dulbecco’s phosphate-buffered saline and incubated
in DMEM (Invitrogen) with glucose or galactose for 16 hours. The
plates were removed from the incubator and allowed to equilibrate
at room temperature for 30 minutes. Next, 100ml of ATPlite 1step
reagent was added to each well and the plates were shaken for
10 minutes at 700 r.p.m. using a rotary plate shaker. The measure-
ments of mitochondrial ATP levels were taken using a Veritas
luminometric plate reader (Turner Biosystems, Madison, WI). The
ATP levels were expressed as nmoles per cell.
Respiration assay
Oxygen consumption rates were measured in whole cells by using a
Fiber optic oxygen monitor (Instech Laboratories, Plymouth Meeting,
PA). Briefly, cells were suspended in 1 ml of respiratory buffer (10 mM
Hepes, pH 7.4, 225 mM mannitol, 75 mM sucrose, 10 mM KCl, 10 mM
KH2PO4, 5 mM MgCl2, and 1 mg ml
–1 BSA) at a concentration of
2 106 cells per ml at 37 1C in a magnetically stirred 1.2 ml chamber.
The decrease in O2 concentration in the sealed chamber was
measured as cellular oxygen consumption by an O2 fiber optic sensor.
Baseline respiration was recorded for 2 minutes before 2ml aliquots of
0.1 mM rotenone (Sigma Aldrich, St Louis, MO) were added until total
inhibition of complex I was obtained. Cell membrane integrity was
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controlled by measuring succinate-driven respiration (10ml of 0.1 M
adenosine diphosphate plus 20ml of 1 M succinate, pH 7.4) before and
after digitonin permeabilization. Cells were permeabilized using 2ml of
5 mg ml–1 digitonin (Sigma Aldrich) per 1 106 cells. Maximum
uncoupled respiration rate was obtained by the addition of 2ml of
2.5 mM carbonyl cyanide m-chlorophenylhydrazone (data not shown).
Finally, inhibited respiration was measured after the addition of 2ml of
200 mM potassium cyanide (data not shown).
Western blotting analysis of OXPHOS complexes
Cybrid cells were collected and resuspended in RIPA buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 5mg ml–1
Aprotinin, 5mg ml–1 Leupeptin, 1% Triton X-100, 1% Sodium
deoxycholate, and 0.1% SDS; Sigma Aldrich). Protein content
was assessed by Coomassie staining. Protein (20mg) was separated
by 12% SDS-PAGE electrophoresis and transferred onto a nitrocellu-
lose membrane (Bio-Rad, Hercules, CA). MitoProfile Total OXPHOS
Rodent WB Antibody Cocktail (MitoSciences, Eugene, OR) containing
five monoclonal antibodies against the 20 kDa subunit of complex I,
ND6, CII-30 kDa, CIII-Core protein 2, CIV subunit I, and CV-a
subunit, was used to detect complex I–V subunits, respectively. The
membrane was stripped and re-blotted with rabbit b-actin mAb (Cell
Signaling Technology, Danvers, MA) to normalize protein-loading
levels. Dilutions of different antibodies for immunoblotting and
subsequent detection by the enhanced chemiluminescence ECL plus
system (GE Healthcare Biosciences, Pittsburgh, PA) were carried out
according to the manufacturer’s protocol.
Statistical analysis
Data are represented as mean±SEM of five clones. All experiments
were performed at least three times. Statistical significance between
any two groups was determined using the two-tailed Student’s t-test.
The P-values of o0.05 were considered to be significant.
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